Business
Moderna vaccine shows signs of working in older adults – The Australian Financial Review
The results offer a more complete picture of the vaccine’s safety for a group at increased risk of severe complications from the COVID-19 virus.
Moderna is already testing the higher dose in a large Phase III trial, the final stage before seeking emergency authorisation or approval.
Side effects, which included headache, fatigue, body aches, chills and injection site pain, were deemed mainly mild to moderate.
In at least two cases, however, volunteers had severe reactions.
One developed a grade three fever, which is classified as 102.2 degrees Fahrenheit (39°C) or above, after receiving the lower vaccine dose. Another developed fatigu…
Continue Reading
